Discussions regarding legislative and regulatory issues, including appropriations, pertaining to the use and application of psychedelic medicines. Issues pertaining to controlled substances rescheduling National Defense Authorization Act (NDAA)
2026 · 3rd Quarter (July 1 - Sep 30)
COMPASS PATHWAYS INC.
Filed by COMPASS PATHWAYS INC..
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 20, 2026
- Income
- Not reported
- Expenses
- $210,000.00
- Registrant
- COMPASS PATHWAYS INC.
- Client
- COMPASS PATHWAYS INC.
- Filing UUID
- 63642a38-bfd7-4501-9fd3-e6c521f49a78
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.